Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.67 USD | -5.11% | -3.47% | -44.52% |
05-10 | Ocuphire Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-11 | Ocuphire Pharma Enrolls 1st Patient in Phase 3 Trial of Visual Acuity Treatment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-44.52% | 43.29M | |
+38.59% | 727B | |
-7.89% | 347B | |
+15.66% | 319B | |
+0.24% | 274B | |
+13.32% | 238B | |
+7.05% | 204B | |
-6.05% | 203B | |
+4.23% | 161B | |
-1.70% | 160B |
- Stock Market
- Equities
- OCUP Stock
- News Ocuphire Pharma, Inc.
- Ocuphire Pharma Gets FDA Approval for Ryzumvi Opthlamic Solution, FDA Website Shows